Search Results

Heart Hospital of New Mexico at Lovelace Medical Center and GE HealthCare announced HHNM as the first location in the United States to install GE HealthCare’s latest Allia Image Guided System Pulse, which was designed to provide exceptional image quality and improve workflow for the diagnosis and treatment of cardiovascular diseases.

BioCryst Pharmaceuticals, Inc. announced that the Federal Commission for Protection against Health Risks in Mexico has granted approval for oral, once-daily ORLADEYO® for the prophylaxis of hereditary angioedema attacks in adults and pediatric patients 12 years of age or older.

The Chemours Company, a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, announced that the Mexican government has lifted its prior water intake restrictions, enabling the Company to resume normal operations at its titanium dioxide manufacturing facility in Altamira, Mexico.

Myriad Genetics, Inc., a leader in genetic testing and precision medicine, announced the addition of a new Universal Plus Panel to its Foresight® Carrier Screen.

The Comisión Federal para la Protección contra Riesgos Sanitarios has approved CTL Amedica Corporation’s MONET™ Anterior Cervical Interbody Fusion System for use in Mexico.

The new combination, dubbed Alyftrek, is designed to improve on the Trikafta, a product that generated sales of $8.9 billion in 2023. It’s welcome good news for Vertex following last week’s subpar clinical results for its non-opioid analgesic.